Abhijeet Anant Rakshasbhuvankar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Abhijeet Anant Rakshasbhuvankar has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Karen Simmer
A Department of Neonatal Paediatrics , King Edward Memorial Hospital for Women , Perth , Australia
4 shared publications - Jennifer Jane Pillow
School of Human Sciences, The University of Western Australia, Perth, Western Australia, Australia
3 shared publications Lakshmi Nagarajan
Department of Neurology; Perth Children's Hospital; Nedlands Australia
3 shared publicationsElizabeth A. Nathan
Women and Infants Research Foundation, King Edward Memorial Hospital, Subiaco, Western Australia, Australia
2 shared publicationsS.K. Patole
Department of Neonatal Paediatrics, King Edward Memorial Hospital for Women, Perth, Australia; Centre for Neonatal Research and Education, University of Western Australia, Perth, Australia
2 shared publicationsSanjay K Patole
Neonatal Clinical Care Unit, King Edward Memorial Hospital for Women , Subiaco, Western Australia, Australia Paediatric Division, Medical School, The University of Western Australia and Telethon Kids Institute , Crawley, Western Australia, Australia
2 shared publications
Latest Publications
- 11 August 2025
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2025 (8) , CD013546
Amplitude-integrated electroencephalography compared with conventional video-electroencephalography for detection of neonatal seizures
Conventional video-electroencephalography (cEEG) is the reference standard for diagnosing and managing neonatal seizures. However, continuous bedside cEEG services are not available in most neonatal units. Hence, an alternative and relatively simple method called amplitude-integrated EEG (aEEG), which uses a limited number of scalp electrodes, has become popular. aEEG allows continuous bedside monitoring of the electrical activity of the brain in neonates. The primary objective of the review was to assess the accuracy of aEEG against the reference standard cEEG for the detection of 'neonates with seizures' and 'individual seizures'. Detection of 'neonates with seizures' refers to the ability of the test to correctly identify a 'neonate' as 'seizure positive' or 'seizure negative' based on the detection of at least one seizure episode in the entire aEEG recording. Detection of 'individual seizures' refers to the ability of the test to correctly identify 'individual' seizure episodes within the same neonate rather than just diagnosing the neonate as 'seizure positive' or 'seizure negative'. We searched CENTRAL, MEDLINE, Embase, clinical trials registries, and grey literature (Open Grey, Trove, and American Doctoral Dissertations) to 26 July 2022. We did not apply any language or publication status restrictions or any other filters. We included prospective and retrospective studies investigating the accuracy of aEEG (index test) against the reference standard cEEG for the detection of neonatal seizures. To be eligible for inclusion, the studies must have compared aEEG with simultaneously recorded cEEG. There was no restriction on the number of leads, use of raw EEG traces, or experience and training of an aEEG interpreter. cEEG should have been recorded using at least nine electrodes and interpreted by a qualified person experienced in the interpretation of neonatal cEEG. Working independently, two review authors collected data from the included studies in a prespecified form and assessed the quality of the included studies using the QUADAS-2 tool. For the outcome of 'neonates with seizures', we used a bivariate mixed-effects regression model to conduct a meta-analysis to derive pooled sensitivity, specificity, positive and negative likelihood ratios (LR), and their respective 95% confidence intervals (CI). We generated a summary receiver operating characteristic (SROC) curve to display the results of individual studies. We calculated post-test probabilities based on Bayes' theorem through Fagan nomograms. For the outcome of 'individual seizures', pooling of data was not possible because of the 'unit of analysis' issue. Instead, we performed a narrative synthesis. We assessed the certainty of the evidence using GRADE guidelines. We included 16 studies (562 infants) in the systematic review, of which only two studies interpreted the aEEGs prospectively at the bedside. Out of 16 studies, three studies (97 infants) described the accuracy of aEEG only for detecting 'infants with seizures', three studies (72 infants) described only 'individual seizures', while 10 studies (393 infants) described the accuracy of aEEG for detecting both. Ten of 16 studies were conducted in term and late preterm infants. Half of the included studies did not use raw EEG traces. Fourteen studies reported outcomes based only on retrospective interpretation. Ten of 16 studies used four electrodes (making this the most common approach amongst the included studies), and 10 studies' aEEG recordings exceeded six hours. Only two included studies used a seizure detection algorithm. In 14 studies, a neonatal or neurology consultant performed aEEG interpretation, and most (in 10 of 14 studies) had prior experience in aEEG interpretation. Accuracy of aEEG to diagnose 'neonates with seizures'. The only two prospective studies (53 participants) which interpreted aEEGs 'live' at the bedside, reported sensitivities of zero and 0.57 and specificities of 0.82 and 0.92, respectively. Meta-analysis of 13 studies (490 neonates) found that aEEG had a pooled sensitivity of 0.71 (95% CI 0.57 to 0.83), specificity of 0.84 (95% CI 0.59 to 0.95), positive LR of 4.50 (95% CI 1.55 to 13.04), and negative LR of 0.34 (95% CI 0.22 to 0.53) for the detection of 'neonates with seizures'. However, when we analysed only studies with low risk of bias (3 studies), sensitivity (0.56, 95% CI 0.02 to 0.99) and specificity (0.78, 95% CI 0.60 to 0.90) were even lower. There was significant statistical heterogeneity, which could not be explained based on threshold effect and exploratory analyses of forest plots. We graded the certainty of the evidence as low, in view of the high or unclear risk of bias in many studies, imprecision, and significant heterogeneity. Accuracy of aEEG to detect 'individual seizures' in neonates. The reported sensitivities of aEEG for the detection of 'individual seizures' ranged from 0 to 0.86 (13 studies, 465 neonates). We rated the certainty of the evidence as low. The common causes of missed seizures on aEEG (i.e. false negative) as reported by studies were short duration of seizures, localisation of seizures away from aEEG leads, low voltage, and inexperienced interpreter. The false-positive rates were high when interpreted live at the bedside and if the interpreters were inexperienced. Artefacts resulting from muscle movement, patting, hiccups, and insufficient electrode attachment were other common causes of false-positive results. Low-certainty evidence suggests that aEEG has only moderate sensitivity and specificity for detecting 'neonates with seizures', and its ability to detect 'individual seizures' varies widely. These findings suggest that aEEG may not be sufficiently accurate for diagnosing neonatal seizures as it can under-diagnose or over-diagnose seizures. Studies with low risk of bias are needed to address the issue definitively.
- 11 August 2025
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2025 (8) , CD013546
Amplitude-integrated electroencephalography compared with conventional video-electroencephalography for detection of neonatal seizures
Conventional video-electroencephalography (cEEG) is the reference standard for diagnosing and managing neonatal seizures. However, continuous bedside cEEG services are not available in most neonatal units. Hence, an alternative and relatively simple method called amplitude-integrated EEG (aEEG), which uses a limited number of scalp electrodes, has become popular. aEEG allows continuous bedside monitoring of the electrical activity of the brain in neonates. The primary objective of the review was to assess the accuracy of aEEG against the reference standard cEEG for the detection of 'neonates with seizures' and 'individual seizures'. Detection of 'neonates with seizures' refers to the ability of the test to correctly identify a 'neonate' as 'seizure positive' or 'seizure negative' based on the detection of at least one seizure episode in the entire aEEG recording. Detection of 'individual seizures' refers to the ability of the test to correctly identify 'individual' seizure episodes within the same neonate rather than just diagnosing the neonate as 'seizure positive' or 'seizure negative'. We searched CENTRAL, MEDLINE, Embase, clinical trials registries, and grey literature (Open Grey, Trove, and American Doctoral Dissertations) to 26 July 2022. We did not apply any language or publication status restrictions or any other filters. We included prospective and retrospective studies investigating the accuracy of aEEG (index test) against the reference standard cEEG for the detection of neonatal seizures. To be eligible for inclusion, the studies must have compared aEEG with simultaneously recorded cEEG. There was no restriction on the number of leads, use of raw EEG traces, or experience and training of an aEEG interpreter. cEEG should have been recorded using at least nine electrodes and interpreted by a qualified person experienced in the interpretation of neonatal cEEG. Working independently, two review authors collected data from the included studies in a prespecified form and assessed the quality of the included studies using the QUADAS-2 tool. For the outcome of 'neonates with seizures', we used a bivariate mixed-effects regression model to conduct a meta-analysis to derive pooled sensitivity, specificity, positive and negative likelihood ratios (LR), and their respective 95% confidence intervals (CI). We generated a summary receiver operating characteristic (SROC) curve to display the results of individual studies. We calculated post-test probabilities based on Bayes' theorem through Fagan nomograms. For the outcome of 'individual seizures', pooling of data was not possible because of the 'unit of analysis' issue. Instead, we performed a narrative synthesis. We assessed the certainty of the evidence using GRADE guidelines. We included 16 studies (562 infants) in the systematic review, of which only two studies interpreted the aEEGs prospectively at the bedside. Out of 16 studies, three studies (97 infants) described the accuracy of aEEG only for detecting 'infants with seizures', three studies (72 infants) described only 'individual seizures', while 10 studies (393 infants) described the accuracy of aEEG for detecting both. Ten of 16 studies were conducted in term and late preterm infants. Half of the included studies did not use raw EEG traces. Fourteen studies reported outcomes based only on retrospective interpretation. Ten of 16 studies used four electrodes (making this the most common approach amongst the included studies), and 10 studies' aEEG recordings exceeded six hours. Only two included studies used a seizure detection algorithm. In 14 studies, a neonatal or neurology consultant performed aEEG interpretation, and most (in 10 of 14 studies) had prior experience in aEEG interpretation. Accuracy of aEEG to diagnose 'neonates with seizures'. The only two prospective studies (53 participants) which interpreted aEEGs 'live' at the bedside, reported sensitivities of zero and 0.57 and specificities of 0.82 and 0.92, respectively. Meta-analysis of 13 studies (490 neonates) found that aEEG had a pooled sensitivity of 0.71 (95% CI 0.57 to 0.83), specificity of 0.84 (95% CI 0.59 to 0.95), positive LR of 4.50 (95% CI 1.55 to 13.04), and negative LR of 0.34 (95% CI 0.22 to 0.53) for the detection of 'neonates with seizures'. However, when we analysed only studies with low risk of bias (3 studies), sensitivity (0.56, 95% CI 0.02 to 0.99) and specificity (0.78, 95% CI 0.60 to 0.90) were even lower. There was significant statistical heterogeneity, which could not be explained based on threshold effect and exploratory analyses of forest plots. We graded the certainty of the evidence as low, in view of the high or unclear risk of bias in many studies, imprecision, and significant heterogeneity. Accuracy of aEEG to detect 'individual seizures' in neonates. The reported sensitivities of aEEG for the detection of 'individual seizures' ranged from 0 to 0.86 (13 studies, 465 neonates). We rated the certainty of the evidence as low. The common causes of missed seizures on aEEG (i.e. false negative) as reported by studies were short duration of seizures, localisation of seizures away from aEEG leads, low voltage, and inexperienced interpreter. The false-positive rates were high when interpreted live at the bedside and if the interpreters were inexperienced. Artefacts resulting from muscle movement, patting, hiccups, and insufficient electrode attachment were other common causes of false-positive results. Low-certainty evidence suggests that aEEG has only moderate sensitivity and specificity for detecting 'neonates with seizures', and its ability to detect 'individual seizures' varies widely. These findings suggest that aEEG may not be sufficiently accurate for diagnosing neonatal seizures as it can under-diagnose or over-diagnose seizures. Studies with low risk of bias are needed to address the issue definitively.
- 24 August 2024
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 110 (2) , 228
Should we use an ‘accelerated’ course of antenatal corticosteroids?
- 24 August 2024
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 110 (2) , 228
Should we use an ‘accelerated’ course of antenatal corticosteroids?
- 7 September 2023
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 111, 206-214
Effects of bumetanide on neonatal seizures: A systematic review of animal and human studies
- 7 September 2023
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 111, 206-214
Effects of bumetanide on neonatal seizures: A systematic review of animal and human studies
- 28 September 2021
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 114 (6) , 2084-2096
Vitamin A supplementation in very-preterm or very-low-birth-weight infants to prevent morbidity and mortality: a systematic review and meta-analysis of randomized trials
A previous systematic review showed that intramuscular vitamin A supplementation reduced the risk of bronchopulmonary dysplasia (BPD) in very-low-birth-weight (VLBW) infants. However, more recent studies have questioned this finding. Our objective was to synthesize current evidence on vitamin A supplementation in very-preterm (n = 2471) in the qualitative and 15 studies (n = 2248) in the quantitative synthesis. Moderate-certainty evidence suggested a beneficial effect of vitamin A for decreasing the risk of BPD at 36 wk postmenstrual age (RR: 0.83; 95% CI: 0.74, 0.93; numbers needed to treat for an additional beneficial outcome: 16; 95% CI: 9, 53; 9 studies, n = 1752; P = 0.002). Subgroup analysis suggested that the beneficial effect was limited to infants with baseline vitamin A intake −1 · d−1. Both enteral and parenteral routes were effective. Vitamin A supplementation did not have adverse effects and did not alter mortality before discharge (12 studies, n = 1917) or neurodevelopmental outcomes at 18–22 mo (1 study, n = 538). The benefit of vitamin A supplementation for reducing BPD is likely to be limited to infants with baseline vitamin A intake −1 · d−1 and is not affected by the route of administration.
- 28 September 2021
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 114 (6) , 2084-2096
Vitamin A supplementation in very-preterm or very-low-birth-weight infants to prevent morbidity and mortality: a systematic review and meta-analysis of randomized trials
A previous systematic review showed that intramuscular vitamin A supplementation reduced the risk of bronchopulmonary dysplasia (BPD) in very-low-birth-weight (VLBW) infants. However, more recent studies have questioned this finding. Our objective was to synthesize current evidence on vitamin A supplementation in very-preterm (n = 2471) in the qualitative and 15 studies (n = 2248) in the quantitative synthesis. Moderate-certainty evidence suggested a beneficial effect of vitamin A for decreasing the risk of BPD at 36 wk postmenstrual age (RR: 0.83; 95% CI: 0.74, 0.93; numbers needed to treat for an additional beneficial outcome: 16; 95% CI: 9, 53; 9 studies, n = 1752; P = 0.002). Subgroup analysis suggested that the beneficial effect was limited to infants with baseline vitamin A intake −1 · d−1. Both enteral and parenteral routes were effective. Vitamin A supplementation did not have adverse effects and did not alter mortality before discharge (12 studies, n = 1917) or neurodevelopmental outcomes at 18–22 mo (1 study, n = 538). The benefit of vitamin A supplementation for reducing BPD is likely to be limited to infants with baseline vitamin A intake −1 · d−1 and is not affected by the route of administration.
- 27 June 2021
- Published by Springer Nature
- p. 99-110
Rating Certainty of the Evidence Using GRADE Guidelines
- 27 June 2021
- Published by Springer Nature
- p. 99-110
Rating Certainty of the Evidence Using GRADE Guidelines
- 1 January 2021
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 147 (1)
Enteral Vitamin A for Reducing Severity of Bronchopulmonary Dysplasia: A Randomized Trial
BACKGROUND AND OBJECTIVES: Evidence suggests that intramuscular vitamin A reduces the risk of bronchopulmonary dysplasia (BPD) in preterm infants. Our objective was to compare enteral water-soluble vitamin A with placebo supplementation to reduce the severity of BPD in extremely preterm infants. METHODS: We conducted a double-blind randomized controlled trial in infants P = .73). Enteral vitamin A did not affect diagnosis of BPD or other clinical outcomes. Plasma retinol levels were significantly higher in the vitamin A group versus the placebo group on day 28 and at 34 weeks’ PMA. CONCLUSIONS: Enteral water-soluble vitamin A supplementation improves plasma retinol levels in extremely preterm infants but does not reduce the severity of BPD.
- 1 January 2021
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 147 (1)
Enteral Vitamin A for Reducing Severity of Bronchopulmonary Dysplasia: A Randomized Trial
BACKGROUND AND OBJECTIVES: Evidence suggests that intramuscular vitamin A reduces the risk of bronchopulmonary dysplasia (BPD) in preterm infants. Our objective was to compare enteral water-soluble vitamin A with placebo supplementation to reduce the severity of BPD in extremely preterm infants. METHODS: We conducted a double-blind randomized controlled trial in infants P = .73). Enteral vitamin A did not affect diagnosis of BPD or other clinical outcomes. Plasma retinol levels were significantly higher in the vitamin A group versus the placebo group on day 28 and at 34 weeks’ PMA. CONCLUSIONS: Enteral water-soluble vitamin A supplementation improves plasma retinol levels in extremely preterm infants but does not reduce the severity of BPD.
- 1 April 2020
- Published by Elsevier in Early Human Development
- Vol. 143, 105011
Inter-rater reliability of amplitude-integrated EEG for the detection of neonatal seizures
- 1 April 2020
- Published by Elsevier in Early Human Development
- Vol. 143, 105011
Inter-rater reliability of amplitude-integrated EEG for the detection of neonatal seizures
- 9 March 2020
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2020 (3)
Amplitude-integrated electroencephalography compared with conventional video-electroencephalography for detection of neonatal seizures
This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: Our primary objective is to assess the accuracy of aEEG against the reference standard cEEG for detection of 'neonates with seizures' and 'individual seizures'. Detection of 'neonates with seizures': this refers to the ability of the index test to identify a 'neonate' as 'seizure positive' or 'seizure negative' correctly based on the detection of at least one seizure episode in the entire aEEG recording of the neonate. Detection of 'individual seizures': this refers to the ability of the index test to identify an 'individual' seizure episode within the same neonate correctly rather than just diagnosing the neonate as 'seizure positive' or 'seizure negative'. Diagnosis of an 'individual seizure' episode is important for optimal management of seizures. If data are available, we will perform subgroup analysis for seizure detection where duration of monitoring is less than or equal to six hours. This subgroup is particularly important as six hours is the cut‐off point to decide whether infants with hypoxic ischaemic encephalopathy require therapeutic hypothermia (Shankaran 2005).
- 9 March 2020
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2020 (3)
Amplitude-integrated electroencephalography compared with conventional video-electroencephalography for detection of neonatal seizures
This is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: Our primary objective is to assess the accuracy of aEEG against the reference standard cEEG for detection of 'neonates with seizures' and 'individual seizures'. Detection of 'neonates with seizures': this refers to the ability of the index test to identify a 'neonate' as 'seizure positive' or 'seizure negative' correctly based on the detection of at least one seizure episode in the entire aEEG recording of the neonate. Detection of 'individual seizures': this refers to the ability of the index test to identify an 'individual' seizure episode within the same neonate correctly rather than just diagnosing the neonate as 'seizure positive' or 'seizure negative'. Diagnosis of an 'individual seizure' episode is important for optimal management of seizures. If data are available, we will perform subgroup analysis for seizure detection where duration of monitoring is less than or equal to six hours. This subgroup is particularly important as six hours is the cut‐off point to decide whether infants with hypoxic ischaemic encephalopathy require therapeutic hypothermia (Shankaran 2005).
- 28 February 2020
- Published by S. Karger AG in Neonatology
- Vol. 117 (3) , 365-368
Saliva for Assessing Vitamin A Status in Extremely Preterm Infants: A Diagnostic Study
Background: Salivary measurement of hormones and vitamins is gaining prominence as a minimally invasive procedure with the negligible potential for harm. We aimed to assess the utility of saliva for assessing vitamin A status in extremely preterm infants. Methods: Paired saliva and blood samples were collected at 4 weeks of age from infants born Results: Thirty infants were recruited with a median (IQR) gestation and birth weight of 26.2 weeks (24.8–27.2) and 865 g (718–1,002), respectively. An adequate volume of saliva (>50 µL) was obtained in 68%. There was no significant correlation (Spearman’s correlation coefficient = 0.16, p = 0.3) between individual plasma and salivary retinol levels. Bland-Altman analysis showed wide limits of agreement (–113 to +119%) between individual plasma and salivary retinol levels. Conclusion: Individual vitamin A status cannot be determined reliably from saliva in extremely preterm infants using current collection materials and analysis techniques.
- 28 February 2020
- Published by S. Karger AG in Neonatology
- Vol. 117 (3) , 365-368
Saliva for Assessing Vitamin A Status in Extremely Preterm Infants: A Diagnostic Study
Background: Salivary measurement of hormones and vitamins is gaining prominence as a minimally invasive procedure with the negligible potential for harm. We aimed to assess the utility of saliva for assessing vitamin A status in extremely preterm infants. Methods: Paired saliva and blood samples were collected at 4 weeks of age from infants born Results: Thirty infants were recruited with a median (IQR) gestation and birth weight of 26.2 weeks (24.8–27.2) and 865 g (718–1,002), respectively. An adequate volume of saliva (>50 µL) was obtained in 68%. There was no significant correlation (Spearman’s correlation coefficient = 0.16, p = 0.3) between individual plasma and salivary retinol levels. Bland-Altman analysis showed wide limits of agreement (–113 to +119%) between individual plasma and salivary retinol levels. Conclusion: Individual vitamin A status cannot be determined reliably from saliva in extremely preterm infants using current collection materials and analysis techniques.